pegfilgrastim
Selected indexed studies
- Pegfilgrastim. (Drugs, 2002) [PMID:12010086]
- Pegfilgrastim-jmdb/MYL-1401H: A Pegfilgrastim Biosimilar. (BioDrugs, 2019) [PMID:30701419]
- Pegfilgrastim. (Expert Opin Biol Ther, 2002) [PMID:12517276]
_Worker-drafted node — pending editorial review._
Connections
pegfilgrastim is a side effect of
Sources
- Pegfilgrastim. (2002) pubmed
- Pegfilgrastim-jmdb/MYL-1401H: A Pegfilgrastim Biosimilar. (2019) pubmed
- Pegfilgrastim. (2002) pubmed
- Two decades of pegfilgrastim: what have we learned? Where do we go from here? (2023) pubmed
- Pharmacokinetics of pegfilgrastim. (2003) pubmed
- Pegfilgrastim on febrile neutropenia in pediatric and adolescent cancer patients: a systematic review and meta-analysis. (2023) pubmed
- Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma. (2021) pubmed
- Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia. (2017) pubmed
- Pegfilgrastim-induced Aortitis: Cardiovascular Diagnosis in the Oncologic Setting. (2022) pubmed
- LA-EP2006: A Pegfilgrastim Biosimilar. (2019) pubmed